MetLife Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
6,497
-435
| -6% | -$15.7K | ﹤0.01% | 2109 |
|
|
2025
Q1 | $216K | Buy |
6,932
+57
| +0.8% | +$1.77K | ﹤0.01% | 2157 |
|
|
2024
Q4 | $175K | Buy |
6,875
+19
| +0.3% | +$485 | ﹤0.01% | 2361 |
|
|
2024
Q3 | $194K | Sell |
6,856
-154
| -2% | -$4.36K | ﹤0.01% | 2305 |
|
|
2024
Q2 | $185K | Sell |
7,010
-234
| -3% | -$6.17K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $220K | Buy |
7,244
+17
| +0.2% | +$516 | ﹤0.01% | 2148 |
|
|
2023
Q4 | $203K | Sell |
7,227
-138
| -2% | -$3.88K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $200K | Buy |
7,365
+10
| +0.1% | +$271 | ﹤0.01% | 2207 |
|
|
2023
Q2 | $226K | Sell |
7,355
-349
| -5% | -$10.7K | ﹤0.01% | 2192 |
|
|
2023
Q1 | $278K | Buy |
7,704
+17
| +0.2% | +$613 | ﹤0.01% | 2015 |
|
|
2022
Q4 | $304K | Buy |
7,687
+137
| +2% | +$5.41K | ﹤0.01% | 1981 |
|
|
2022
Q3 | $303K | Sell |
7,550
-183
| -2% | -$7.35K | ﹤0.01% | 2014 |
|
|
2022
Q2 | $325K | Sell |
7,733
-7,378
| -49% | -$310K | ﹤0.01% | 1967 |
|
|
2022
Q1 | $589K | Buy |
+15,111
| New | +$589K | ﹤0.01% | 1670 |
|